Metcalfe Sylvia A
Murdoch Childrens Research Institute, Royal Children's Hospital and Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, 3052, Australia,
J Community Genet. 2012 Jul;3(3):193-203. doi: 10.1007/s12687-011-0071-z. Epub 2011 Dec 20.
Discussing carrier screening during preconception consultation in primary care has a number of advantages in terms of promoting autonomy and enabling the greatest range of reproductive choices. For those with a family history of an inherited condition, this ought to be a routine discussion; however, this can be expanded to include the wider population, especially for those conditions for which carrier frequencies are considered relatively common. There is published literature from around the world regarding experiences with carrier screening in primary care for cystic fibrosis, haemoglobinopathies, fragile X syndrome, Tay-Sachs disease and spinal muscular atrophy, although many of these have tended to focus on consultations during rather than before pregnancy. Overall, these studies reveal that population carrier screening is well received by the participants with apparent minimal psychosocial harms; however, challenges exist in terms of approaches to ensure couples receive adequate information to make personally relevant decisions and for ongoing health professional engagement.
在初级保健中进行孕前咨询时讨论携带者筛查,在促进自主性和实现最大范围的生育选择方面具有诸多优势。对于有遗传病家族史的人来说,这应该是一次常规讨论;然而,这一讨论范围可以扩大到更广泛的人群,特别是对于那些携带者频率被认为相对较高的疾病。世界各地都有关于初级保健中进行囊性纤维化、血红蛋白病、脆性X综合征、泰-萨克斯病和脊髓性肌萎缩症携带者筛查经验的文献发表,尽管其中许多文献往往侧重于孕期而非孕前的咨询。总体而言,这些研究表明,人群携带者筛查受到参与者的广泛接受,且明显造成最小的心理社会危害;然而,在确保夫妇获得足够信息以做出个人相关决策以及持续的医疗专业人员参与方面仍存在挑战。